[Intravitreal Bevacizumab injections in a child with choroidal neovascularization--case report].

Abstract

A healthy 11 year old boy with active choroidal neovascularization (CNV) was referred to the Department of Ophthalmology in Wroclaw for unilateral visual deterioration from 2 weeks. The best-corrected visual acuity was counting fingers from 4 meters. Boy was successfully treated with three intravitreal injections of bevacizumab. Intravitreal bevacizumab was well tolerated, choroidal neovascularization involuted, and best-corrected visual acuity improved to 20/32. The boy remained stable for 6 months after injections.

• Authors: Patrycja Krzyzanowska-Berkowska, Anna Barć, Jolanta Oficjalska
• Journal: Klinika oczna (Klin Oczna) Vol. 113 Issue 1-3 Pg. 60-3 ( 2011) ISSN: 0023-2157 [Print] Poland
• Vernacular Title: Iniekcje doszklistkowe bevacizumabu u dziecka z podsiatkówkowa neowaskularyzacja--opis przypadku.
• PMID: 21853954 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Angiogenesis Inhibitors
• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Bevacizumab

Topics

• Angiogenesis Inhibitors (administration & dosage)
• Antibodies, Monoclonal (administration & dosage)
• Antibodies, Monoclonal, Humanized
• Bevacizumab
• Child
• Choroidal Neovascularization (diagnosis, drug therapy)
• Dose-Response Relationship, Drug
• Humans
• Intravitreal Injections
• Male
• Tomography, Optical Coherence (methods)
• Treatment Outcome
• Visual Acuity (drug effects)